Scientific Program
Scientific Program
The 14th International Congress of Endocrine Disorders
22– 24 November 2023, Tehran - Iran
| Time | Type | Title | Speaker | Hall |
| Wednesday Nov. 22 | ||||
| 7:30 - 9:00 Opening Ceremony | Younes Panahi; Vice Chancellor of Research and Technology; Ministry of Health Alireza Zali; Chancellor, Shahid Beheshti University of Medical Sciences | Main Hal | ||
| Plenary Lectures Chairs: Reza Rajabian, Ali Mohammad Mellati, Manouchehr Jazayeri, Navid Saadat | ||||
| 9:00 – 9:30 | Plenary Lecture 1 | Critical thinking in endocrine sciences | Akbar Soltani | Main Hall |
| 9:30 – 10:00 | Plenary Lecture 2 | Precision Endocrinology | Nitin Kapoor | Main Hall |
| 10:00–10:30 | Plenary Lecture 3 | Cell Therapy in Endocrine Disorders | Bagher Larijani | Main Hall |
| 10:30 – 11:00 | Break | |||
| 11:00– 12:30 | Symposium 1 | Pituitary Neuroendocrine Tumors:Mohammad Ebrahim Khamseh | Main Hall | |
| Pitfalls in diagnosis and treatment of Cushings’disease | Majid Valizadeh | |||
| New horizon in medical management ofAcromegaly | Nahid Hashemimadani | |||
| Aggressive Prolactinoma | Bahram Jafar Mohammadi | |||
| Symposium 2 | Gestational Diabetes Mellitus:Fahimeh Ramezani Tehrani | Allameh | ||
| GDM screening & risk factors: National evidence | Samira Behboudi | |||
| Oral antidiabetic agents in GDM management | Fahimeh Ramezani Tehrani | |||
| Neonatal and long term outcomes of children of mothers with GDM | Fahimeh Soheilipour | |||
| Management of diabetes in pregnancy | Yashdeep Gupta | |||
| 12:30 – 13:30 | Prayer & Lunch | |||
13:30– 15:00 | Symposium 3 | Management of Hypothyroidism Atieh Amouzegar | Allameh | |
| Hypothyroidism: Advances in diagnosis, screen in gand prevention | Salman Razvi | |||
| Progress in the management of hypothyroidism | Jacqueline Jonklaas | |||
| Combination treatment of hypothyroidism with levothyroxine plus Liothyronine | Ladan Mehran | |||
Symposium 4 | Diabetic Foot Moderator: Mohammadreza Mohajeri Tehrani Panel: Sasan Sharghi, Mohsen Khoshniat | Kharazmi | ||
| Approach to infection in diabetic foot ulcer | Neda Alijani | |||
| Approach to vascular problems in diabetic footulcer | Behnam Molavi | |||
| Epidermal and platelet derived growth factors indiabetic foot ulcer | Mahboubeh Nazari | |||
| Case discussion: complicated diabetic foot ulcer | Mohammad Reza Amini, MaryamAAlaa | |||
| 15:00– 17:00 | Panel 1 | Oral PresentationsModerator: Azita Zadeh Vakili, Davood Khalili | Allameh | |
| The effect of high-fat feeding, as a metabolicstressor, on pancreatic HB9 protein level andinsulin secretion in Wistar rat dams | Roxana Karbaschi | |||
| Association of dietary fat quality with anthropometric measures in the pediatric age groups | Maedeh Mozafarinia | |||
| Diabetes Mellitus and Cancer Incidence: Aretrospective cohort study | Mina Akbarirad | |||
| Effect of Six Weeks of Swimming Training on FGF21 and PNPLA-3 Genes Expression in Rats withPCOS | Maryam Khalilinejad | |||
| HDL3-C but not HDL2-C as a protective factor for cardiovascular diseases: a nested case-controlstudy in an Iranian population | Maryam Tohidi | |||
| Proinflamatory cytokines decreased in insulin resistance in diabetic mice induced by HFD/STZ:treatment role of Aqueous extract of Artemisiaannual | Forouzan Sadeghi mahalli | |||
| Assessment of the anti-inflammatory and antiglycemic properties of Royal Jelly and Tocotrienolrich fraction in an experimental study: Does irisinmediate these effects? | Naimeh Mesri Alamdari | |||
| Chronic inorganic nitrate administration increases the expression of genes involved in the browning of gonadal adipose tissue in ovariectomized rats | Sajad Jeddi | |||
| The effects of Nigella Sativa oil supplement with aweight-loss diet on anthropometric indices and metabolic status based on polymorphisms of adiponectine and PPAR-gamma2 genes | Nazli Namazi | |||
| Epidemiologic study of neonatal hypothyroidism in Qazvin province (years 2016-2020) | Amene Ahadizadeh | |||
| Thursday Nov. 23 | ||||
| Plenary Lecture Chair: Javad Behjati, Mohammad Ebrahim Khamseh | ||||
| 8:00-8:30 | Plenary Lecture4 | Nuances of Thyroidology : merging science with art | Sarita Bajaj | Main Hall |
8:30– 10:00 | Symposium 5 | Diabetes ManagementModerator: Alireza Esteghamati | Main Hall | |
| Twincretins and triple G Drugs in management of diabetes | Alireza Esteghamati | |||
| IDF initiatives | Peter Schwarz | |||
| Current management of newly diagnosed T2DM | Ralph Defronzo | |||
| Ramadan & diabetes | Shehla Shaikh | |||
| Symposium 6 | Adrenal Disorders Moderator: Hassan Rezvanian | Allameh | ||
| Cell Therapy in Endocrine Disorders | Mojgan Sanjari | |||
| Non classical congenital adrenal hyperplasia | Marayam Razzaghy Azar | |||
| Steroid stewardship | Rakesh Sahay | |||
| Adrenal incidentaloma | Amir Bahrami | |||
| 10:00 – 10:30 | Break | |||
| Plenary Lectures Chairs: Manouchehr Nakhjavani, Saeid Kalantari, Majid Ramezani | ||||
| 10:30-11:00 | Plenary Lecture5 | The Digital Twin in Clinical Endocrinology | Iraj Nabipour | Main Hall |
| 11:00-11:30 | Plenary Lecture6 | Person Centric Management of Obesity:Barophenotype characterization | Sanjay Karla | Main Hall |
| 11:30-12:00 | Plenary Lecture7 | Challenges in managing Diabetes | Syed Abbas Raza | Main Hall |
| 12:00 – 13:00 | Prayer &Lunch | |||
| 13:00 – 14:00 | Iran Endocrine Society - General assembly Allameh Hall | |||
14:00– 15:30 | Symposium 7 | Treatment of Hyperthyroidism Moderator: Manouchehr Nakhjavani | Allameh | |
| Treatment of hyperthyroidism: past and present | Douglas Ross | |||
| Practical hints for long-term anti-thyroid drug treatment | Fereidoun Azizi | |||
| Symposium 8 | Diabetes and Technology Moderator: Adel Jahed | Kharazmi | ||
| Continuous glucose monitoring: recent advancements | Adel Jahed | |||
| Insulin delivery systems | Hamid Aghaei | |||
| CGM in people with T2DM | Mojtaba Malek | |||
15:30– 17:00 | Symposium 9 | Precision Medicine Moderator: Maryam Daneshpour | Allameh | |
| Precision Medicine and How to Establish in Iran:Diabetes as an example | Maryam Daneshpour | |||
| Genetic of Maturity on set diabetes mellitus in young(MODY) in TCGS | Sara Asgarian | |||
| The Genetic risk score of type 1 diabetes in TCGS | Maryam Moazam | |||
| Genome-wide association of type 2 diabetes in TCGS | Mahdi Akbarzadeh | |||
| The Role of Artificial Intelligence in Precision Medicine | Hossein Lanjanian | |||
15:30– 17:00 | Panel 2 | Oral Presentations Moderator: Mohammad Ebrahim Khamseh. Zohreh Mousavi, Hossein Dabbaghmanesh | Kharazmi | |
| Subclinical hyperthyroidism and adverse pregnancy out comes | Sima Nazarpour | |||
| Association between new indices and the carotidintima-media thickness in type 2 diabetes mellitus | Laily Najafi | |||
| Can Empagliflozin be used in patients with type 1diabetes: Results of a 12-week, double-blind,randomized, placebo-controlled clinical trial | Farzad Najafipour | |||
| The association between blood pressure, quality of life, and emotional states in adults with different disease awareness and commitment to treatment | Mahdieh Niknam | |||
| Effects of astaxanthin on cardio-metabolic risk factors in the pediatric age groups | Maryam Aref | |||
| The effect of melatonin supplementation on serum levels of leptin and adiponectin: A systematic review and meta-analysis of randomized clinical trials | Sevana Daneghian | |||
| Investigating the impact of substituting clarifiedbutter or ghee with canola oil on liver steatosis andenzymes, fasting blood glucose, and insulin resistance in individuals suffering from non-alcoholicfatty liver disease | Fatemeh Maleki Sedgi | |||
| The relationship between thyroid hormone alterations in acute phase of COVID-19 and postCOVID syndrome among severe and critical COVID19 patients: A bidirectional cohort | Sara Pezeshki | |||
Friday Nov. 24 | ||||
8:30– 10:00 | Symposium10 | Osteoporosis: Diagnostic Pitfalls & Management Moderator: Farhad Hosseinpanah | Allameh | |
| Risk stratification | Hossein Dabbaghmanesh | |||
| Sequential therapy in Osteoporosis | Mike Lewiecki | |||
| Diabetes and osteoporosis | Mojtaba Mehrdad | |||
Symposium11 | Management of Thyroid Cancer Moderator: Zohreh Mousavi | Kharazmi | ||
| Thyroid Cancer: integrating basic science & clinical practice | Mehdi Hedayati | |||
| Active surveillance for managing papillary thyroid cancer | Michael Tuttle | |||
| Management of local neck recurrence of thyroid cancer | Hossein Gharib | |||
| Health related quality of life in patients with thyroid cancer | Donald McLeod | |||
Symposium12 | Obesity Symposium Moderator: Mohammad Afkham | Parvin | ||
| Epidemiology and diagnosis | Mohammad Afkhami | |||
| Oral anti-obesity medications | Ozra Akha | |||
| GLP-1 RA in treatment of obesity | Farzaneh Sarvghadi | |||
| Dual & triple Agonists | Hajieh Bibi Shahbazian | |||
| 10:00 – 10:30 | Break | |||
10:30– 12:00 | Symposium13 | Cardiorenal Protection in T2DM Moderator: Farzad Hadaegh | Allameh | |
| Hypertension management in people with T2DM | Bijan Iraj | |||
| Lipid management: Treat to target vs. high intensity | Hengameh Abdi | |||
| Diabetic kidney disease and cardiovascular outcome | Zohreh Maghsoomi | |||
| Heart failure management in people with T2DM | Reza Ghanavati | |||
| Symposium14 | Thyroid Eye Disease Moderator: Farzad Pakdel | Kharazmi | ||
| Clinical features and classification of TED | Peter Dolman | |||
| Pearls and pitfalls in management of TED | Farzad Pakdel | |||
| Management of hyperthyroidism in patients with TED(Positioning of iodine ablation therapy vs surgicalablation) | Fatemeh Esfahanian | |||